FDA Warns of Stroke, Dissection Risk With MS Drug Alemtuzumab FDA Warns of Stroke, Dissection Risk With MS Drug Alemtuzumab

Thirteen cases of ischemic and hemorrhagic stroke and cervicocephalic arterial dissection associated with alemtuzumab prompt FDA to add warnings to the drug label.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news